Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.

By A. Brueggemann, D. Griffiths, Emma Meats, T. Peto, D. Crook, B. Spratt. Journal of Infectious Diseases, 2003

671 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/9a5018b5e345bde64a4999257d5fc235e7908b90

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

Martin C. J. Maiden

In Microbiology

Citations in the corpus

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. (2010, background): “In addition, characteristics of circulating pneumococcal strains that place them at selective advantage, such as the ability to cause invasive disease [36, 43], prevalence in nasopharyngeal carriage [36], resistance to commonly prescribed antibiotics [7, 43], and age-based susceptibility to differen”
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. (2007, background): “A ranking of serotype-specific odds ratios for invasiveness that also included PCV7 serotypes showed that serotype 19A had the seventh highest odds ratio for its ability to cause invasive disease [23].”
Multi-locus sequence typing: a tool for global epidemiology. (2003, methodology): “Applications and limitations of MLST data MLST is increasingly applied as a routine typing tool that enables international comparison of isolates [31‐36] .I t has been applied to problems as diverse as the emergence of antibiotic-resistant variants [29,37], the association of particular genotypes wi”
How Clonal Is Staphylococcus aureus? (2003, background): “For example, population studies of the gram-positive pathogen S. pneumoniae have demonstrated that isolates from carriers are more diverse than those from disease patients (20, 28, 34), and a recent study suggests that different clones (as defined by MLST) and serotypes show differing potential to c”